Last Updated：2025/11/21
The new agonistic monoclonal antibody showed promising results in early trials by enhancing T-cell responses against tumors.
See correct answer
The new agonistic monoclonal antibody showed promising results in early trials by enhancing T-cell responses against tumors.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
